• English
  • Eesti

    The Estonian medicinal products market in second quarter 2018

    Printer-friendly version

    Estonian drug statistics is based on wholesalers’ reports. The statistics of human medicinal products includes sales to general and hospital pharmacies and to other institutions, i.e. state and scientific institutions. The statistics of veterinary medicinal products includes sales to general and veterinary pharmacies, veterinarians and to other institutions. The medicinal products market is expressed in wholesale prices which includes the price of the manufacturer and wholesaler’s mark-up and does not include the VAT.

    Human medicines

    In the second quarter of 2018 the medicinal products market increased 6.9% reaching to 80.3 million euros. Estonian human medicines market of previous five years shows also an increasing trend:

    Figure 1. Estonian human medicines market in second quarter 2014-2018

    Sales to general pharmacies were 54.4 million euros, sales to hospital pharmacies 25.1 million euros and sales to other institutions 1.0 million euros.

    Prescription sales covered most of the medicinal products market, being 69.6 million euros. The turnovers of over the counter sales and hospital package sales were 10.2 million euros and 0.5 million euros.

    Based on ATC classification, the most sold medicines by turnover, were antineoplastic and immunomodulating agents (16.9 million euros), antiinfectives for systemic use (11.7 million euros) and alimentary tract and metabolism medicines (9.5 million euros).

    Defined Daily Dose (DDD) is the assumed average dose per day for the drug used in its main indication in adults. Defined Daily Dose per thousand inhabitants a day (DDD/1000/day) expresses the proportion of the population within a defined area treated daily with certain drugs.

    According to DDD/1000/day the most consumed medicines in the second quarter of 2018 were cardiovascular system drugs (427 DDD/1000/day), alimentary tract and metabolism drugs (171 DDD/1000/day) and nervous system medicines (123 DDD/1000/day).

    In the second quarter of 2018, over 3700 different medicinal preparation packages and 1200 active substances were marketed in Estonia.


    The Estonian veterinary medicinal products market was 3.8 million euros in wholesale prices in the second quarter of 2018. Compared to the same period in 2017 the turnover increased 12%.

    83% of veterinary medicines were sold to the veterinarians or to the agricultural companies represented by a veterinarian, 9% to the general pharmacies, 7% to the veterinary pharmacies and under 0.1% to other institutions (generally state- and scientific institutions).

    The most sold medicines by turnover were antiparasitic products (1.12 million euros), antiinfectives for systemic use (0.86 million euros) and immunologicals (0.72 million euros). Compared the data of second quarters of the last three years the turnover of antiparasitic products and antiinfectives increased constantly.

    Figure 2. Estonian veterinary medicinal products market share between ATCvet groups in the II quarter 2016-2018